The board (the "Board") of directors of CANbridge Pharmaceuticals Inc. (the "Company") hereby announces that Dr. Derek Paul Di Rocco ("Dr. Di Rocco") has tendered his resignation as a non-executive Director and a member of the nomination and corporate governance committee of the Company (the "Nomination and Corporate Governance Committee") with effect from November 23, 2023 (the "Effective Date"), as he would like to devote more time to his personal engagement. Following Dr. Di Rocco's resignation, he has ceased to be a member of the Nomination and Corporate Governance Committee, with effect from the Effective Date.